133 Recruiting Non Small Cell Lung Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Non Small Cell Lung Cancer
Related Conditions
Top Recruiting Non Small Cell Lung Cancer Studies
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
📍 Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey
View Study & Checklist ➔Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC
📍 Beverly Hills Cancer Center — Beverly Hills, California
View Study & Checklist ➔Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
📍 Research Site — Columbus, Georgia
View Study & Checklist ➔Assessment of Precision Irradiation in Early NSCLC and Interstitial Lung Disease
📍 Alberta Health Services, Cross Cancer Institude — Edmonton, Alberta
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
📍 Highlands Oncology Group - Duplicate 2 — Springdale, Arkansas
View Study & Checklist ➔A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
📍 City of Hope — Duarte, California
View Study & Checklist ➔Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
📍 Highlands Oncology Group — Springdale, Arkansas
View Study & Checklist ➔A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
📍 BC Cancer -Vancouver Island — Vancouver, British Columbia
View Study & Checklist ➔Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
📍 UCLA Hematology/Oncology — Santa Monica, California
View Study & Checklist ➔Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
📍 Emory University — Atlanta, Georgia
View Study & Checklist ➔Study of NEO-201 in Solid Tumors Expansion Cohorts
📍 National Cancer Institute — Bethesda, Maryland
View Study & Checklist ➔A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
📍 BRCR Global — Plantation, Florida
View Study & Checklist ➔UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade
📍 UC Davis Medical Center — Sacramento, California
View Study & Checklist ➔CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer
📍 Pacific Cancer Medical Center, Inc — Anaheim, California
View Study & Checklist ➔Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients
📍 Rocky Mountain Cancer Center, LLP — Boulder, Colorado
View Study & Checklist ➔ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
📍 XCancer/Dothan Hematology & Oncology - 1114 — Dothan, Alabama
View Study & Checklist ➔Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
📍 Baptist Alliance Miami Cancer Institute — Miami, Florida
View Study & Checklist ➔Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
📍 Georgetown University — Washington D.C., District of Columbia
View Study & Checklist ➔Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
📍 NYU Langone — New York, New York
View Study & Checklist ➔Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
📍 Site 9618 — Tucson, Arizona
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
📍 Highlands Oncology Group — Fayetteville, Arkansas
View Study & Checklist ➔Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial
📍 St. Joseph's Healthcare Hamilton — Hamilton, Ontario
View Study & Checklist ➔Using ctDNA to Determine Therapies for Lung Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔Biology of Young Lung Cancer Study: The YOUNG LUNG Study
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
📍 Mayo Clinic Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
📍 BAPTIST ALLIANCE - MCI (Data Collection Only) — Miami, Florida
View Study & Checklist ➔The Effect of Beta-glucan in Non-Small Cell Lung Cancer
📍 James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
📍 Laura and Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York
View Study & Checklist ➔Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
📍 Cedars-Sinai Cancer at Beverly Hills (THO) — Beverly Hills, California
View Study & Checklist ➔Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
📍 Stanford University — Stanford, California
View Study & Checklist ➔A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
📍 MD Anderson Cancer Hospital — Houston, Texas
View Study & Checklist ➔Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
📍 Beverly Hills Cancer Center — Beverly Hills, California
View Study & Checklist ➔Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔